IBDEI0ZI ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17313,1,4,0)
 ;;=4^V45.09
 ;;^UTILITY(U,$J,358.3,17313,1,5,0)
 ;;=5^OTH SP CARD DEV IN SITU
 ;;^UTILITY(U,$J,358.3,17313,2)
 ;;=^303421
 ;;^UTILITY(U,$J,358.3,17314,0)
 ;;=V45.69^^88^1059^9
 ;;^UTILITY(U,$J,358.3,17314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17314,1,4,0)
 ;;=4^V45.69
 ;;^UTILITY(U,$J,358.3,17314,1,5,0)
 ;;=5^OTH STATES FOLLOW SURG OF EYE
 ;;^UTILITY(U,$J,358.3,17314,2)
 ;;=^317957
 ;;^UTILITY(U,$J,358.3,17315,0)
 ;;=V45.82^^88^1059^10
 ;;^UTILITY(U,$J,358.3,17315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17315,1,4,0)
 ;;=4^V45.82
 ;;^UTILITY(U,$J,358.3,17315,1,5,0)
 ;;=5^PERCUT TRANS CORO ANGIO
 ;;^UTILITY(U,$J,358.3,17315,2)
 ;;=^303425
 ;;^UTILITY(U,$J,358.3,17316,0)
 ;;=V45.89^^88^1059^11
 ;;^UTILITY(U,$J,358.3,17316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17316,1,4,0)
 ;;=4^V45.89
 ;;^UTILITY(U,$J,358.3,17316,1,5,0)
 ;;=5^POSTSURGICAL STATES NEC
 ;;^UTILITY(U,$J,358.3,17316,2)
 ;;=^276679
 ;;^UTILITY(U,$J,358.3,17317,0)
 ;;=V45.51^^88^1059^12
 ;;^UTILITY(U,$J,358.3,17317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17317,1,4,0)
 ;;=4^V45.51
 ;;^UTILITY(U,$J,358.3,17317,1,5,0)
 ;;=5^PRESENCE OF IUD
 ;;^UTILITY(U,$J,358.3,17317,2)
 ;;=^98125
 ;;^UTILITY(U,$J,358.3,17318,0)
 ;;=V45.52^^88^1059^13
 ;;^UTILITY(U,$J,358.3,17318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17318,1,4,0)
 ;;=4^V45.52
 ;;^UTILITY(U,$J,358.3,17318,1,5,0)
 ;;=5^PRESENCE OF SUBDERM CONTRA
 ;;^UTILITY(U,$J,358.3,17318,2)
 ;;=^303423
 ;;^UTILITY(U,$J,358.3,17319,0)
 ;;=V45.59^^88^1059^14
 ;;^UTILITY(U,$J,358.3,17319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17319,1,4,0)
 ;;=4^V45.59
 ;;^UTILITY(U,$J,358.3,17319,1,5,0)
 ;;=5^PRESENCE-OTH CONTRACEP DEV
 ;;^UTILITY(U,$J,358.3,17319,2)
 ;;=^303424
 ;;^UTILITY(U,$J,358.3,17320,0)
 ;;=V45.11^^88^1059^15
 ;;^UTILITY(U,$J,358.3,17320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17320,1,4,0)
 ;;=4^V45.11
 ;;^UTILITY(U,$J,358.3,17320,1,5,0)
 ;;=5^RENAL DIALYSIS STATUS
 ;;^UTILITY(U,$J,358.3,17320,2)
 ;;=^336792
 ;;^UTILITY(U,$J,358.3,17321,0)
 ;;=V45.00^^88^1059^16
 ;;^UTILITY(U,$J,358.3,17321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17321,1,4,0)
 ;;=4^V45.00
 ;;^UTILITY(U,$J,358.3,17321,1,5,0)
 ;;=5^UNSP CARDIAC DEV IN SITU
 ;;^UTILITY(U,$J,358.3,17321,2)
 ;;=^295458
 ;;^UTILITY(U,$J,358.3,17322,0)
 ;;=V45.2^^88^1059^17
 ;;^UTILITY(U,$J,358.3,17322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17322,1,4,0)
 ;;=4^V45.2
 ;;^UTILITY(U,$J,358.3,17322,1,5,0)
 ;;=5^VENTRICULAR SHUNT STATUS
 ;;^UTILITY(U,$J,358.3,17322,2)
 ;;=^295460
 ;;^UTILITY(U,$J,358.3,17323,0)
 ;;=V66.7^^88^1060^34
 ;;^UTILITY(U,$J,358.3,17323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17323,1,4,0)
 ;;=4^V66.7
 ;;^UTILITY(U,$J,358.3,17323,1,5,0)
 ;;=5^ENCOUNTER-PALLIATIVE CARE
 ;;^UTILITY(U,$J,358.3,17323,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,17324,0)
 ;;=V46.2^^88^1061^2
 ;;^UTILITY(U,$J,358.3,17324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17324,1,4,0)
 ;;=4^V46.2
 ;;^UTILITY(U,$J,358.3,17324,1,5,0)
 ;;=5^SUPPLEMENTAL OXYGEN
 ;;^UTILITY(U,$J,358.3,17324,2)
 ;;=^328702
 ;;^UTILITY(U,$J,358.3,17325,0)
 ;;=V46.8^^88^1061^1
 ;;^UTILITY(U,$J,358.3,17325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17325,1,4,0)
 ;;=4^V46.8
 ;;^UTILITY(U,$J,358.3,17325,1,5,0)
 ;;=5^MACHINE DEPENDENCE NEC
 ;;^UTILITY(U,$J,358.3,17325,2)
 ;;=^295465
 ;;^UTILITY(U,$J,358.3,17326,0)
 ;;=V69.2^^88^1062^3
 ;;^UTILITY(U,$J,358.3,17326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17326,1,4,0)
 ;;=4^V69.2
 ;;^UTILITY(U,$J,358.3,17326,1,5,0)
 ;;=5^HI-RISK SEXUAL BEHAVIOR
 ;;^UTILITY(U,$J,358.3,17326,2)
 ;;=^303474
 ;;
 ;;$END ROU IBDEI0ZI
